Fig. 1From: Oridonin inhibits pancreatic cancer cell migration and epithelial-mesenchymal transition by suppressing Wnt/β-catenin signaling pathwayORI inhibits SW1990 cell migration. a Cell viability was determined by using a CCK-8 assay. b–e Cell migration was determined by using wound healing and transwell assay. The migrative ability of ORI group (7 and 15 μM) was compared with that in the control group. *P < 0.05, **P < 0.01, ***P < 0.001 vs. control groupBack to article page